These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34986335)

  • 1. Metabolite discovery: Biochemistry's scientific driver.
    Giera M; Yanes O; Siuzdak G
    Cell Metab; 2022 Jan; 34(1):21-34. PubMed ID: 34986335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Unknown Metabolomics Mixture Compounds by Combining NMR, MS, and Cheminformatics.
    Leggett A; Wang C; Li DW; Somogyi A; Bruschweiler-Li L; Brüschweiler R
    Methods Enzymol; 2019; 615():407-422. PubMed ID: 30638535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two elephants in the room: new hybrid nuclear magnetic resonance and mass spectrometry approaches for metabolomics.
    Bingol K; Brüschweiler R
    Curr Opin Clin Nutr Metab Care; 2015 Sep; 18(5):471-7. PubMed ID: 26154280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass Spectroscopy as an Analytical Tool to Harness the Production of Secondary Plant Metabolites: The Way Forward for Drug Discovery.
    Ahmad F; Nadeem H
    Methods Mol Biol; 2023; 2575():77-103. PubMed ID: 36301472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics: Biochemistry's new look.
    Blow N
    Nature; 2008 Oct; 455(7213):697-700. PubMed ID: 18833281
    [No Abstract]   [Full Text] [Related]  

  • 6. Challenges in Identifying the Dark Molecules of Life.
    Monge ME; Dodds JN; Baker ES; Edison AS; Fernández FM
    Annu Rev Anal Chem (Palo Alto Calif); 2019 Jun; 12(1):177-199. PubMed ID: 30883183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics.
    Marshall DD; Powers R
    Prog Nucl Magn Reson Spectrosc; 2017 May; 100():1-16. PubMed ID: 28552170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in metabolite identification.
    Wishart DS
    Bioanalysis; 2011 Aug; 3(15):1769-82. PubMed ID: 21827274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research.
    Emwas AH
    Methods Mol Biol; 2015; 1277():161-93. PubMed ID: 25677154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowns and unknowns in metabolomics identified by multidimensional NMR and hybrid MS/NMR methods.
    Bingol K; Brüschweiler R
    Curr Opin Biotechnol; 2017 Feb; 43():17-24. PubMed ID: 27552705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR Spectroscopy-Based Metabolic Profiling of Biospecimens.
    Sengupta A; Weljie AM
    Curr Protoc Protein Sci; 2019 Dec; 98(1):e98. PubMed ID: 31763785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Methodology for Known Metabolite Identification in Metabonomics/Metabolomics: Topological Metabolite Identification Carbon Efficiency (tMICE).
    Sanchon-Lopez B; Everett JR
    J Proteome Res; 2016 Sep; 15(9):3405-19. PubMed ID: 27490438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR-Guided Mass Spectrometry for Absolute Quantitation of Human Blood Metabolites.
    Nagana Gowda GA; Djukovic D; Bettcher LF; Gu H; Raftery D
    Anal Chem; 2018 Feb; 90(3):2001-2009. PubMed ID: 29293320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated pipeline for de novo metabolite identification using mass-spectrometry-based metabolomics.
    Peironcely JE; Rojas-Chertó M; Tas A; Vreeken R; Reijmers T; Coulier L; Hankemeier T
    Anal Chem; 2013 Apr; 85(7):3576-83. PubMed ID: 23368721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UHPLC-QTOF-MS/MS-SPE-NMR: A Solution to the Metabolomics Grand Challenge of Higher-Throughput, Confident Metabolite Identifications.
    Bhatia A; Sarma SJ; Lei Z; Sumner LW
    Methods Mol Biol; 2019; 2037():113-133. PubMed ID: 31463842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective.
    Rankin NJ; Preiss D; Welsh P; Burgess KE; Nelson SM; Lawlor DA; Sattar N
    Atherosclerosis; 2014 Nov; 237(1):287-300. PubMed ID: 25299963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational strategies for metabolite identification in metabolomics.
    Wishart DS
    Bioanalysis; 2009 Dec; 1(9):1579-96. PubMed ID: 21083105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear magnetic resonance: a key metabolomics platform in the drug discovery process.
    Leenders J; Frédérich M; de Tullio P
    Drug Discov Today Technol; 2015 Jun; 13():39-46. PubMed ID: 26190682
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.